Pharmafile Logo

Top-10 Best Practices for Virtual Publication Planning and Development

Virtual publication planning is rapidly evolving with new digital tools, but are you truly optimizing your strategy? Our article dives into the challenges of this new landscape, from data security to stakeholder collaboration, and reveals essential best practices to overcome them and maximize the impact of your publications.

- PMLiVE

The landscape of publication planning is constantly evolving with the rise of novel digital tools, artificial intelligence, and virtual collaboration platforms. As a result, traditional barriers to effective and efficient publication planning and development are being broken down, while new challenges related to compliance, data security, and global collaboration in the virtual setting have emerged.

To set your virtual publication planning and development project up for success, there are some best practices that all life science teams should follow.

1. Engage Your Key Stakeholders Early and Often

One of the major benefits of virtual publication planning is the ability to engage your key stakeholders on a regular basis to speed up project timelines. After the most suitable stakeholders, whether Key Opinion Leader (KOL), healthcare provider (HCP), or patient co-authors, have been identified and contracted, their involvement should be immediate. Involving them in the early planning process ensures that their input is considered from the get-go, minimizing the need for last-minute revisions to the plan. Likewise, engaging them on a regular basis keeps the project top-of-mind, allows iterative feedback and adjustments, and facilitates seamless course correction.

Frequent engagements also help maintain open and transparent communication throughout the project, which helps manage expectations and build authentic relationships. Aim to foster a culture where participants feel comfortable giving honest feedback.

2. Consider Diverse Perspectives

A diverse group of male and female healthcare providers are centered around a computer as part of a virtual publication planning projectAnother key advantage of the virtual version of publication planning and development is that more diverse stakeholders can be engaged. In this case, diversity might refer to co-authors from different geographic areas, various medical specialties and levels of seniority, and demographics. To cater to these diverse stakeholders, there is a need to effectively manage time zone, scheduling, and language differences. This can be partially achieved through pre-meeting polls to identify the meeting times that work for the most people. Alternatively, leveraging an asynchronous (over time, anytime) collaboration platform allows all participants to participate on their own schedule, irrespective of their comfort with spoken English, geography, and professional and personal commitments. The asynchronous format also enables an equal share of voice among participants, no matter their seniority and level of extroversion.

3. Manage Your Project Timelines and Milestones

Publication projects tend to fall apart in the absence of a clear strategy and behind-the-scenes project management. While it’s key to be agile (see #10), having predetermined timelines and regular milestones will ensure that the project stays on track. This means that the touchpoint dates and topics should be set and communicated to all stakeholders as early as possible. It also means that the scope of literature review needed and the target journal should be identified from the beginning to ensure adherence to the timelines. Likewise, information on the co-authors’ affiliations and conflicts of interest should be collected upfront, in a standardized format, to avoid bottlenecks at the time of submission.

To this end, there is no shortage of project management tools that can be used to keep the project on track. If leveraging a Pharma-compliant virtual collaboration platform, a few come with project management support, progress monitoring, and reporting, which help with all of the above…

To read more tips, visit our blog 

 

This content was provided by Impetus Digital

Company Details

 Latest Content from  Impetus Digital 

Beat inflation with virtual meetings and programs

At the time of writing, the average inflation rate worldwide sits at 7.4%, the highest it’s been for decades. Here in Canada, the inflation rate is not forecasted to come back down...

Engaging KOLs & Gaining Insights in Pharma’s New Normal

Kaitlin Anstett, Senior Medical Advisor at Theratechnologies, shares her unique insights into the way Medical Affairs teams are changing the way they are engaging and interacting with their most important...

There’s No Going Back: How COVID-19 will Change Pharma Forever

Munther Baara, VP Product Strategy and Innovation at EDETEK, discusses all things clinical trials. Especially, we discuss the current gaps and the impact of COVID-19 on the way Pharma approaches...

Powering Rapid Cognitive Analysis with AI

Dr. Tom Sawyer, CFO at Cognetivity Neurosciences, discusses the benefits of AI-driven dementia detection technology for patients, health care providers, and clinical research.

KOL Ambassador Program & Podcast Creation: A Customer Story

Leveraging Impetus Digital’s best-in-class synchronous (real-time) and asynchronous (over-time, anytime) tools, our client facilitated a virtual ambassador program with three oncologist key opinion leaders (KOLs) from South Korea.The client’s main objectives...

Importance of Emotional Intelligence in Pharma and Medical Affairs

Emma Lynch, Founder of EQ Vibration & Quadrant 2 Medical, explores a number of interesting topics related to Medical Affairs. Among many other things, she discusses the importance of emotional...

Virtual product launch planning: the ultimate playbook

We walk you through, step-by-step, how cross-functional teams can seamlessly work together and overcome the many obstacles associated with traditional product launches.

Artificial Intelligence for Identifying and Monitoring Cognitive Decline

Liam Kaufman, CEO & Co-founder of Winterlight Labs, explores a range of topics related to AI, machine learning, natural language processing, digital biomarkers, and human-computer interactions in healthcare.

Trust and transparency in Pharma & healthcare: impact of the COVID-19 pandemic

While it is obvious that trust in life science and healthcare companies is suboptimal, exactly how to improve the public’s trust is unclear...